Xi-Yang Tang
Overview
Explore the profile of Xi-Yang Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
190
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Zhao P, Wang X, Xie L, Li Y, Zhang S, et al.
Phytomedicine
. 2025 Jan;
138:156382.
PMID: 39842371
Background: The concept of a Quality marker (Q-marker) has emerged as a crucial tool for ensuring the safety and efficacy of Traditional Chinese Medicine (TCM) formulas. However, significant challenges remained...
2.
Tang X, Shu Z, Zhao P, Wei W, Fan C, Yao Z, et al.
Carbohydr Polym
. 2024 Jul;
342:122422.
PMID: 39048245
Zhu-Ling decoction (ZLD), a classical traditional Chinese medicine (TCM) formula, is used for the treatment of chronic kidney diseases. However, the structure and activity of absorbed oligosaccharides (OSs) in ZLD...
3.
Shu Z, Fan C, Wei H, Li Z, Norimoto H, Tang X, et al.
J Sep Sci
. 2023 Jul;
46(17):e2300331.
PMID: 37438987
An efficient strategy for the identification of potential nephroprotective substances in Zhu-Ling decoction has been established with the integration of absorbed components characterization, pharmacokinetics, and activity evaluation. A qualitative method...
4.
Tang X, Zeng J, Wang X, Xu W, Zhao P, Fan C, et al.
J Sep Sci
. 2022 Nov;
46(2):e2200723.
PMID: 36401831
Codonopsis radix was commonly used as food materials or herbal medicines in many countries. However, the comprehensive analysis of chemical constituents, and in vivo xenobiotics of Codonopsis radix remain unclear....
5.
Li R, Fan C, Xu W, Wei W, Wang X, Li Z, et al.
J Pharm Biomed Anal
. 2022 Nov;
223:115157.
PMID: 36379101
Qi-Lin pill (QLP) is an effective traditional Chinese medicine prescription (TCMP) that has been used for the treatment of the oligoasthenozoospermia in China. Recently, some articles described the pharmacological effects...
6.
Tang X, Luo Z, Xiong Y, Yang J, Shi A, Zheng K, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358792
Cancer remains a serious social health problem, and immunotherapy has become the major treatments in tumor treatment. Additionally, improving the efficiency and safety of treatment is necessary. Further, more therapy...
7.
Tang X, Xiong Y, Zhao Y, Yang J, Shi A, Zheng K, et al.
Front Immunol
. 2022 Oct;
13:1014053.
PMID: 36268014
Rational: Lung cancer is the most common tumor worldwide, with the highest mortality rate and second highest incidence. Immunotherapy is one of the most important treatments for lung adenocarcinoma (LUAD);...
8.
Tang X, Xiong Y, Shi X, Zhao Y, Shi A, Zheng K, et al.
Biomark Res
. 2022 Jul;
10(1):49.
PMID: 35831836
Immunotherapy has become the major treatment for tumors in clinical practice, but some intractable problems such as the low response rate and high rates of immune-related adverse events still hinder...
9.
Tang X, Dai Z, Zeng J, Li Z, Fan C, Yao Z, et al.
J Sep Sci
. 2022 Apr;
45(13):2177-2189.
PMID: 35478323
In the present study, a specific and sensitive approach using ultra-high-performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry was developed and validated for the quantitative analysis of 14...
10.
Tang X, Xiong Y, Shi A, Sun Y, Han Q, Lv Y, et al.
Transl Lung Cancer Res
. 2022 Apr;
11(3):404-419.
PMID: 35399566
Background: The mechanisms involved in the malignant progression of lung adenocarcinoma (LUAD) are still inconclusive. Fibrinogen-like protein 1 () and are a pair of immune checkpoints that create an inhibitory...